Stenocare A/S reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was DKK 2.85 million. Net loss was DKK 3.34 million compared to DKK 4.85 million a year ago. Basic loss per share from continuing operations was DKK 0.29 compared to DKK 0.42 a year ago.
For the full year, sales was DKK 4.49 million compared to DKK 1.89 million a year ago. Net loss was DKK 16.3 million compared to DKK 12.73 million a year ago. Basic loss per share from continuing operations was DKK 1.4 compared to DKK 1.09 a year ago.